CPH2 aims to license out 3GW/yr of production by 2030
CPH2 secures first licence deal for electrolysers
UK company’s patented membrane-free electrolyser to be produced in Ireland by GHFG
UK hydrogen technology company Clean Power Hydrogen (CPH2) has signed a 20-year deal for the production of 2GW of its patented membrane-free electrolyser under licence by renewables joint venture GHFG at a new facility in Ireland. Production is expected to start in 2023 under the deal, which is CPH2’s first licence agreement with another manufacturer. “A core component of our business model is licensing out production to other companies, while also producing a certain number of units ourselves,” says Jon Duffy, CEO of CPH2. “By 2030, our goal is to produce approximately 1GW[/yr] at CPH2 facilities and 3GW[/yr] under licence.” 2GW – Capacity to be produced under licence agreement Lice
Also in this section
4 February 2025
This premier event is poised to address the evolving technology and investment demands of North America’s thriving chemical and pharmaceutical sectors
4 February 2025
Sector awaits clarity on tax credits and loan programmes amid mixed signals from the Trump presidency
30 January 2025
Both the US and Canada have ambitious plans for their hydrogen sectors
30 January 2025
The region may account for only a small share of active hydrogen projects currently, but it has lots more in the pipeline
